Cryogenic freezing of biological material is not only possible, it happens routinely in fertility clinics, blood banks, and research labs around the world. Cells, embryos, sperm, and small tissue samples are frozen and successfully thawed every day. But the question most people are really asking is whether you can freeze a whole human body and bring it back, and there the answer shifts dramatically. The gap between freezing a vial of cells and preserving an entire organ, let alone an entire person, turns out to be one of the hardest problems in biology.
What Ice Does to Living Cells
The fundamental enemy of cryogenic preservation is ice. Water expands when it freezes, and ice crystals are rigid, jagged structures that can physically puncture cell membranes. But the damage is more subtle than simple impalement. As ice forms outside a cell, it locks up pure water and leaves behind an increasingly concentrated solution of salts and other dissolved molecules. The remaining liquid channels between ice crystals shrink, and the cells trapped in those channels face intense osmotic stress, losing water rapidly as they try to equalize with their increasingly salty surroundings.1PubMed. Freezing of living cells: mechanisms and implications Early theories blamed the concentrated solutes themselves, but more recent work points to the physical squeezing of cells into ever-narrower unfrozen channels as a major source of damage.
If cooling is too fast, a different problem takes over. Water inside the cell does not have time to leave, and ice crystals form directly within the cytoplasm. Research on cultured mammalian cells suggests this intracellular freezing happens when the osmotic pressure difference across the cell membrane becomes large enough to damage the membrane itself, allowing ice to nucleate inside.2Biophysical Journal. The Phenomenon of Intracellular Freezing in Cultured Mammalian Cells So cooling too slowly causes one kind of injury, cooling too fast causes another, and the optimal rate sits in a narrow band that varies from one cell type to the next.
Vitrification and the Glass Transition
The most promising strategy for avoiding ice altogether is vitrification, which means cooling a liquid so rapidly that its molecules never have time to arrange themselves into a crystal lattice. Instead of freezing, the liquid hardens into an amorphous glass. Think of it as pressing pause on the molecular motion without any of the structural rearrangement that defines true freezing.
Water by itself is extremely difficult to vitrify because it crystallizes so readily. Confined water, depending on the space it occupies, undergoes a glass transition somewhere between roughly minus 100°C and minus 70°C.3PubMed Central. Complexity of confined water vitrification and its glass transition temperature To push bulk solutions into a glassy state at achievable cooling rates, scientists add chemicals called cryoprotectants. These molecules interfere with ice crystal formation by bonding to water molecules and stabilizing disordered arrangements that cannot easily be incorporated into an ice lattice. DMSO, one of the most widely used cryoprotectants, works largely this way, disrupting the orderly hydrogen-bond networks that water needs in order to crystallize.4PubMed Central. How cryoprotectants work: hydrogen-bonding in low-temperature vitrified solutions
The early breakthroughs in vitrification came in the 1980s, when researchers independently showed that mouse embryos could be vitrified and survive. Those experiments revealed that the choice of cryoprotectant mattered enormously. Propylene glycol turned out to be too toxic at high concentrations, but glycerol-based solutions produced viable embryos at rates comparable to conventional slow freezing.5Dove Medical Press. Vitrification: the pioneering past to current trends and perspectives of cryopreserving human embryos, gametes and reproductive tissue Those results opened the door to modern reproductive medicine’s heavy reliance on frozen eggs and embryos.
The Toxicity Trade-Off
Here is the central dilemma of cryopreservation: to vitrify tissue, you need a high concentration of cryoprotectant, but cryoprotectants are themselves poisonous to cells. At the concentrations required for vitrification, they cause real biological harm.6PubMed. Cryoprotective agent toxicity interactions in human articular chondrocytes Toxicity generally rises with concentration, and some agents are worse than others. Ethylene glycol tends to be among the least toxic, while others cause more damage at the same dose.7PubMed Central. Rapid quantification of multi-cryoprotectant toxicity using an automated liquid handling method
DMSO illustrates the problem well. At concentrations above about 40%, it binds irreversibly to proteins and can unfold them. It reacts with specific biological molecules like lens proteins and glutathione. It thins and destabilizes cell membranes, and at high enough concentrations it can destroy the membrane’s bilayer structure entirely.8PubMed Central. Cryoprotectant Toxicity: Facts, Issues, and Questions All of these effects get worse at higher temperatures, which creates a practical problem: you need to load the cryoprotectant into tissue at a temperature warm enough for it to diffuse, but every second it sits in the tissue at that temperature, it does more damage.
Researchers have spent decades trying to thread this needle. One approach uses mixtures of several cryoprotectants at lower individual concentrations, hoping the ice-blocking effects add up while the toxic effects of any single agent stay manageable. Another uses computational models to optimize how quickly the cryoprotectant is loaded and at what temperature, minimizing the total toxic exposure.9PubMed Central. Model-Guided Design and Optimization of CPA Perfusion Protocols for Whole Organ Cryopreservation Progress has been real but incremental.
What Already Works
Despite these challenges, cryopreservation of individual cells and small tissue samples is a mature, reliable technology. Fertility medicine is the most visible success story. A Dutch population-based study of over a thousand women who underwent fertility preservation found that the majority had oocytes (eggs) cryopreserved, with a median of 13 eggs banked per woman. These frozen eggs were later thawed and used in embryo transfers with results good enough to make the procedure standard of care for cancer patients facing treatment that might destroy their fertility, as well as for women banking eggs for non-medical reasons.10Human Reproduction. Outcomes of female fertility preservation with cryopreservation of oocytes or embryos in the Netherlands: a population-based study
Blood banks routinely freeze red blood cells and platelets. Stem cell transplant centers freeze bone marrow and cord blood. Research laboratories preserve cell lines indefinitely in liquid nitrogen. The common thread is that all of these involve relatively small volumes of relatively uniform biological material. A vial of cells is a few milliliters. An egg is a single cell. Even a blood bag is thin enough that cryoprotectant can reach every cell quickly and cooling rates can be controlled precisely.
Why Whole Organs Remain Out of Reach
Scale changes everything. A human kidney is not just a large collection of cells; it is a complex three-dimensional structure with blood vessels of widely varying diameters, multiple tissue types with different freezing tolerances, and regions that are harder to perfuse with cryoprotectant than others. Getting a uniform concentration of cryoprotectant throughout an entire organ before vitrification is a problem that nobody has fully solved.
If some regions of the organ end up with less cryoprotectant than they need, those regions will form ice crystals even if the rest vitrifies successfully. Research on kidney vitrification has noted this as an open question: whether the ice that forms when poorly perfused regions devitrify during rewarming causes serious damage, and whether it can be prevented by improving cryoprotectant distribution.11PubMed. Cryopreservation of organs by vitrification: perspectives and recent advances
There is also the problem of mechanical stress. As a vitrified organ cools further below the glass transition temperature, thermal contraction can create internal stresses large enough to crack the glassy material. Modeling of human kidneys during vitrification found that the tensile stresses generated during storage were below the fracture threshold for the vitrified cryoprotectant solution, but the margins were not large, and the stresses depended heavily on the organ’s size and cooling profile.12Cryobiology. Thermomechanical stress analysis of rabbit kidney and human kidney during cryopreservation by vitrification with the application of radiofrequency heating Larger organs with more complex geometries face higher risk of cracking, which could be catastrophic for any attempt to revive the tissue later.
The Rewarming Problem
Getting tissue cold without ice is only half the battle. Warming it back up is, in many ways, the harder half. If a vitrified sample warms too slowly, water molecules gain enough mobility to organize into ice crystals before the tissue fully thaws. This process, called devitrification, can destroy tissue that survived the initial cooling without a scratch.13Applied Thermal Engineering. Ultra-rapid vitrification and temperature measurement in laser rewarming of vitrified droplets
How fast is fast enough? That depends on the cryoprotectant solution. For one common formulation called DP6, the critical warming rate needed to avoid significant ice formation during thawing was calculated at about 189°C per minute. Adding stabilizing agents like sucrose or butanediol brought that requirement down dramatically, in some cases to as low as 1°C per minute or even less.14PubMed Central. Vitrification tendency and stability of DP6-based vitrification solutions for complex tissue cryopreservation That matters because achieving uniform rapid warming throughout a large organ is extremely difficult with conventional heating methods. The outside warms first while the core stays cold, creating temperature gradients that cause both devitrification and thermal stress.
One of the most promising technologies for solving this is nanowarming. Researchers have demonstrated that iron oxide nanoparticles dispersed throughout a vitrified sample can be excited by a radiofrequency field, generating heat uniformly throughout the entire volume simultaneously. In tests on porcine arteries and heart valve tissue in volumes up to 50 milliliters, nanowarming produced viability that matched controls and outperformed conventional slow warming.15PubMed Central. Improved tissue cryopreservation using inductive heating of magnetic nanoparticles Fifty milliliters is still far from a whole organ, but the approach is scalable in principle, and it represents a genuine shift in how the field thinks about the warming side of the equation.
Animals That Freeze and Survive
Nature has, in a few remarkable cases, already solved problems that human cryobiology is still working on. The wood frog is the standout example. These frogs survive winters in which their bodies literally freeze solid. Their hearts stop beating, their brains go silent, and they show no breathing or movement. Then, when spring arrives, they thaw and resume normal function within hours.16PubMed. Lessons from nature: Leveraging the freeze-tolerant wood frog as a model to improve organ cryopreservation and biobanking
The frog’s trick is chemical preparation. When ice begins to form on the skin, it triggers a massive surge of glucose production that floods the frog’s organs and acts as a natural cryoprotectant.17PubMed. Cryoprotectant Production in Freeze-Tolerant Wood Frogs Is Augmented by Multiple Freeze-Thaw Cycles In subarctic populations, organs shed up to half or even two-thirds of their water content, and the cryoprotectant in the remaining fluid reaches remarkably high concentrations.18PLOS ONE. Cryoprotectants and Extreme Freeze Tolerance in a Subarctic Population of the Wood Frog The frog does not avoid ice formation entirely; it controls where ice forms (outside cells, in extracellular spaces) and protects the cell interiors from damage. It is, in effect, a natural demonstration that vertebrate organs can survive freezing under the right chemical conditions.
Tardigrades take a different approach. These microscopic animals enter a dried-out dormant state called a tun, in which their metabolism effectively stops. In this state they can survive temperatures near absolute zero, radiation levels that would kill most organisms, and even the vacuum of space.19Comparative Biochemistry and Physiology Part A. New insights into survival strategies of tardigrades Their strategy is not vitrification in the cryobiological sense, but it demonstrates that complex animal biology can be paused and restarted, which is philosophically relevant to the broader question of whether suspended animation is possible.
Brain Preservation and the Cryonics Question
For most people asking whether cryogenic freezing is “actually possible,” the real question is about cryonics: can you preserve a human brain well enough to potentially restore a person someday? This is where the science gets speculative, because preservation and revival are very different goals.
On the preservation side, there has been genuine progress. A technique called aldehyde-stabilized cryopreservation, which chemically fixes tissue before vitrifying it, has shown striking results in rabbit brains. Electron microscopy revealed that preserved neurons in the hippocampus were structurally indistinguishable from fresh controls, with intact cell membranes, well-defined nuclear envelopes, and normal-looking mitochondria and other organelles.20Cryobiology. Aldehyde-stabilized cryopreservation The catch is that chemical fixation kills the tissue. The structure is beautifully preserved, but the cells are not alive. This approach preserves the connectome, the wiring diagram of the brain, on the bet that future technology might be able to read it. Whether that bet pays off is a question no current experiment can answer.
Cryonics patients face additional challenges that laboratory specimens do not. Most patients experience some period of warm ischemia, the time between cardiac arrest and the start of the preservation procedure, during which blood flow has stopped and tissue begins to deteriorate. Neurons are more resilient to this than many people assume, with the cascade of cell death playing out over hours rather than the six minutes commonly cited as the limit of ordinary resuscitation.21PubMed Central. Scientific Justification of Cryonics Practice But blood vessels are more vulnerable than neurons to ischemic injury, and damaged blood vessels make it harder to perfuse the brain with cryoprotectant afterward.22PubMed. Vascular and neuronal ischemic damage in cryonics patients So even if the neurons themselves could theoretically survive the delay, the plumbing needed to protect them during cryopreservation may already be compromised.
Why the “Freezing” in Cryonics Is Misleading
Most cryonics organizations do not actually freeze their patients in the conventional sense. They attempt vitrification, using high concentrations of cryoprotectant perfused through the circulatory system before cooling to liquid nitrogen temperatures. The goal is to avoid ice formation entirely. Whether they succeed uniformly throughout the brain and body is uncertain, and the answer probably varies from case to case depending on how quickly the procedure begins after legal death, how well the blood vessels accept perfusion, and how evenly the cryoprotectant distributes.
The philosophical framing matters here too. At least one scholarly analysis has argued that cryonics functions more like a faith-based practice than a scientific one, offering a form of transcendence over death rather than a medically grounded procedure.23PubMed. Cryonics: Science or Religion That framing is harsh, but it captures something real about the gap between what the science can currently demonstrate and what cryonics patients are banking on. The preservation step is based on real cryobiology. The revival step depends on technologies that do not yet exist and may never exist, including the ability to repair molecular-level damage, remove or replace cryoprotectant in a dead brain, and somehow restart biological function in tissue that has been chemically fixed or vitrified for decades.
The Distance Between Here and There
It helps to put the current state of the field in perspective by listing what each scale of biological material requires and where the bottlenecks sit. For single cells and thin tissue samples, the entire pipeline works: loading cryoprotectant, vitrifying, storing indefinitely at liquid nitrogen temperature, rewarming, and recovering viable tissue. For small tissue constructs in the range of a few cubic centimeters, vitrification is achievable and nanowarming technology has shown it can bring them back without ice formation. For whole organs, cryoprotectant distribution remains uneven, rewarming at the necessary rates has not been demonstrated at full organ scale, and nobody has transplanted a vitrified-then-rewarmed organ with normal function. For a whole human body, every one of these problems compounds, plus you face the additional challenge that different tissues have different optimal cryoprotectant concentrations, cooling rates, and warming rates.
The organ transplant crisis has given the field a powerful practical incentive beyond cryonics. If kidneys, hearts, and livers could be banked the way blood and sperm can, it would transform transplant medicine by decoupling organ donation from the frantic time pressure of a few hours between procurement and surgery. That practical motivation has attracted substantial research funding and produced genuine progress. The nanowarming work and the computational modeling of cryoprotectant loading protocols are both aimed squarely at this goal.
Whether cryogenic freezing is “actually possible” depends entirely on what you mean by the phrase. Freezing cells and recovering them alive? Done, every day, in thousands of clinics. Vitrifying small tissues and rewarming them successfully? Demonstrated in the lab. Preserving a whole organ for indefinite storage and transplanting it later? Not yet, but researchers can see a plausible path. Preserving a whole human and reviving them decades from now? That remains an extraordinary claim without anything close to extraordinary evidence, resting on a chain of future breakthroughs that may or may not arrive.